What is MetroGel-Vaginal?
MetroGel-Vaginal is the vaginal treatment health care providers prescribe most for BV.8
MetroGel-Vaginal is clinically proven to cure BV and works directly at the site of infection.7
MetroGel-Vaginal offers convenient once-a-day dosing at bedtime for 5 days.11
3M Pharmaceuticals Home | Prescribing Information

The most commonly reported side effects for MetroGel-Vaginal (metronidazole vaginal gel, 0.75%) include vaginal discharge (12%), Candida cervicitis/vaginitis (6-10%), vulvovaginal irritation (9%), gastrointestinal discomfort (7%), and headache (5%).
Bacterial vaginosis (BV) was formerly known as Gardnerella vaginitis, nonspecific vaginitis, Haemophilus vaginitis, anaerobic vaginosis, and Corynebacterium vaginitis. A clinical diagnosis of BV is usually defined by the presence of a homogeneous vaginal discharge that (a) has a pH >4.5, (b) emits a "fishy" amine odor when mixed with a 10% KOH solution, and (c) contains clue cells on microscopic examination. Gram's stain results consistent with a diagnosis of BV include (a) markedly reduced or absent Lactobacillus morphology, (b) predominance of Gardnerella morphotype, and (c) absent or few white blood cells. Other pathogens commonly associated with vulvovaginitis (eg, Trichomonas vaginalis, Chlamydia trachomatis, Neisseria gonorrhoeae, Candida albicans, and herpes simplex virus) should be ruled out. |
 |